This is the final published version. Available from Springer Nature via the DOI in this record.Background: Understanding variation in stage at diagnosis can inform interventions to improve the timeliness of diagnosis for patients with different cancers and characteristics. Methods: We analysed population-based data on 17 836 and 13 286 East of England residents diagnosed with (female) breast and lung cancer during 2006-2009, with stage information on 16 460 (92%) and 10 435 (79%) patients, respectively. Odds ratios (ORs) of advanced stage at diagnosis adjusted for patient and tumour characteristics were derived using logistic regression. Results :We present adjusted ORs of diagnosis in stages III/IV compared with diagnosis in stages I/II. F...
BACKGROUND: The authors consider whether differences in stage at diagnosis could explain the variati...
We used multiple regression models to assess the influence of disease stage at diagnosis on the 5-ye...
BACKGROUND: We investigate whether differences in breast cancer survival in six high-income countrie...
BACKGROUND: Stage at diagnosis strongly predicts cancer survival and understanding related inequalit...
This is the final published version. Available from Oxford University Press via the DOI in this reco...
BACKGROUND: Stage at diagnosis strongly predicts cancer survival and understanding related inequalit...
BACKGROUND: Stage at diagnosis is a strong predictor of cancer survival. Differences in stage distri...
Background: Stage at diagnosis is a strong predictor of cancer survival. Differences in stage distri...
We used multiple regression models to assess the influence of disease stage at diagnosis on the 5-ye...
Objectives Cancer stage at diagnosis is a determinant of treatment options and survival. Previous re...
Background: Increasing early-stage diagnosis is a priority of health policy in England. Numerous int...
Breast cancer-specific mortality is static in older women despite having fallen in younger age group...
Background Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is an impor...
Background Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is an impor...
This is the final published version. Available from Springer Nature via the DOI in this record.BACKG...
BACKGROUND: The authors consider whether differences in stage at diagnosis could explain the variati...
We used multiple regression models to assess the influence of disease stage at diagnosis on the 5-ye...
BACKGROUND: We investigate whether differences in breast cancer survival in six high-income countrie...
BACKGROUND: Stage at diagnosis strongly predicts cancer survival and understanding related inequalit...
This is the final published version. Available from Oxford University Press via the DOI in this reco...
BACKGROUND: Stage at diagnosis strongly predicts cancer survival and understanding related inequalit...
BACKGROUND: Stage at diagnosis is a strong predictor of cancer survival. Differences in stage distri...
Background: Stage at diagnosis is a strong predictor of cancer survival. Differences in stage distri...
We used multiple regression models to assess the influence of disease stage at diagnosis on the 5-ye...
Objectives Cancer stage at diagnosis is a determinant of treatment options and survival. Previous re...
Background: Increasing early-stage diagnosis is a priority of health policy in England. Numerous int...
Breast cancer-specific mortality is static in older women despite having fallen in younger age group...
Background Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is an impor...
Background Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is an impor...
This is the final published version. Available from Springer Nature via the DOI in this record.BACKG...
BACKGROUND: The authors consider whether differences in stage at diagnosis could explain the variati...
We used multiple regression models to assess the influence of disease stage at diagnosis on the 5-ye...
BACKGROUND: We investigate whether differences in breast cancer survival in six high-income countrie...